Overview
Lobbying Costs
550,000€
Financial year: Jan 2018 - Dec 2018
Lobbyists (Full time equivalent)
1 Fte (3)
Lobbyists with EP accreditation
3
High-level Commission meetings
6
Lobbying Costs over the years
-
Info
Boehringer Ingelheim
EU Transparency Register
289777818743-24 First registered on 10 Sep 2015
Goals / Remit
Boehringer Ingelheim
Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2018, Boehringer Ingelheim achieved net sales of around 17.5 billion euros. R&D expenditure of almost 3.2 billion euros corresponded to 18.1 per cent of net sales.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards humankind and the environment.
More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.Main EU files targeted
EU Health Policy
EU Research Policy
EU Trade Policy
Innovative Medicines Initiative
Health Technology Assessment
Data Protection Regulation
Medicine's Adaptive Pathways to Patients
Veterinary policy and legislation
EU Environment PolicyAddress
Head Office
Boehringer Ingelheim
Binger Straße 173
Ingelheim 55216
GERMANYEU Office
Boehringer Ingelheim
Corporate Office EU
Brüssel 1000
BELGIUM -
People
Total lobbyists declared
3
Employment time Lobbyists 50% 1 25% 2 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
3 accreditations were / are live (in bold) for the selected state of 09 Jul 2019
Name Start date End Date Matthias KAGERBAUER 04 Apr 2024 02 Oct 2024 Christine WILMINK 13 Jul 2023 12 Jul 2024 Andreas Preising 02 Sep 2023 01 Sep 2024 Mr Andreas PREISING 02 Sep 2023 15 Apr 2024 Ms Christine WILMINK 13 Jul 2023 15 Apr 2024 Mr Matthias KAGERBAUER 24 Feb 2023 11 Mar 2024 Ms Joanna INGLIS 22 Nov 2022 26 Nov 2022 Mr Darren KINSELLA 15 Nov 2022 15 Nov 2023 Mr Andreas PREISING 07 Sep 2022 02 Sep 2023 Ms Christine WILMINK 19 Jul 2022 13 Jul 2023 Mr Matthias KAGERBAUER 30 Jan 2022 28 Jan 2023 Mr Darren KINSELLA 27 Oct 2021 27 Oct 2022 Mr Andreas PREISING 16 Sep 2021 07 Sep 2022 Ms Christine WILMINK 10 Aug 2021 19 Jul 2022 Mr Matthias KAGERBAUER 11 Feb 2021 30 Jan 2022 Mr Andreas PREISING 16 Sep 2020 16 Sep 2021 Ms Christine WILMINK 27 Aug 2020 10 Aug 2021 Ms Angelica GALPERTI 28 Feb 2020 01 Aug 2020 Mr Matthias KAGERBAUER 23 Jan 2020 01 Feb 2021 Ms Corinne PHILIPPE-REVERSAT 26 Nov 2019 26 Nov 2020 Mr Andreas PREISING 20 Sep 2019 16 Sep 2020 Ms Angelica GALPERTI 20 Sep 2019 28 Feb 2020 Ms Nina Brkuljan 16 Apr 2019 22 Jan 2020 Ms Corinne PHILIPPE-REVERSAT 07 Dec 2018 26 Nov 2019 Mr Andreas PREISING 27 Sep 2018 20 Sep 2019 Ms Carolin SCHUMACHER 08 May 2018 05 Aug 2018 Ms Nina Brkuljan 21 Apr 2018 16 Apr 2019 Mr Andreas PREISING 10 Oct 2017 27 Sep 2018 Mr Andreas PREISING 15 Oct 2016 10 Oct 2017 Ms Carolin SCHUMACHER 23 May 2017 08 May 2018 Ms Caroline Edlund Toulemonde 23 May 2017 17 May 2018 Ms Nina Brkuljan 27 Apr 2017 21 Apr 2018 Andreas Preising 15 Oct 2016 05 Oct 2017 Complementary Information
Several employees of Boehringer Ingelheim worked on activities relevant to the EU Transparency Register, but only 3 in 2017 spent more than 10 % of time on the activities falling within the scope of the register.
Person in charge of EU relations
Mr Andreas Preising (Head of Corporate Office EU)
Person with legal responsibility
Mr Hubertus von Baumbach (Chair of the Board of Managing Directors)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
EFPIA (European Federation of Pharmaceutical Industries and Associations)
EBG (European Biosimilars Group)
IFAH - Animal Health Europe
EARA (European Animal Research Association)Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2018 - Dec 2018
Lobbying costs for closed financial year
550,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
NO
Other activities
None declared
Meetings
Meetings
6 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 28 Jul 2022 Location Salzburg, Austria Subject Current economic and geopolitical challenges. European strategic autonomy. Consequences of Covid-19 for European health policy. Cabinet Cabinet of Commissioner Johannes Hahn Portfolio Budget and Administration Attending - Johannes Hahn (Commissioner)
- Barbara Herbolzheimer (Cabinet member)
Other Lobbyists -
Date 08 Oct 2021 Location Paianias Subject Pharma policies Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Krikou (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 16 Feb 2021 Location Videoconference Subject Pact for Skills roundtable with the representatives of the health sector. Cabinet Cabinet of Commissioner Nicolas Schmit Portfolio Jobs and Social Rights Attending - Christoph Nerlich (Cabinet member)
- Nicolas Schmit (Commissioner)
- Anouk Faber (Cabinet member)
Other Lobbyists - European Federation of Nurses Associations
- European Health Management Association asbl
- Siemens Healthineers AG
- European Federation of Public Service Unions
- European Hospital and Healthcare Employers' Association
- Oncompass Medicine
- Standing Committee of European Doctors
- European Patients' Forum (EPF)
-
Date 16 Feb 2021 Location Videoconference Subject Pact for Skills roundtable with the representatives of the health sector Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Agnieszka Skonieczna (Cabinet member)
- Thierry Breton (Commissioner)
- Eszter Batta (Cabinet member)
Other Lobbyists - European Health Management Association asbl
- Siemens Healthineers AG
- European Patients' Forum (EPF)
- Oncompass Medicine
- European Hospital and Healthcare Employers' Association
- European Federation of Public Service Unions
- Standing Committee of European Doctors
- European Federation of Nurses Associations
-
Date 27 Nov 2018 Location Brussels Subject MFF Cabinet Cabinet of Vice-President Günther Oettinger Portfolio Budget & Human Resources Attending - Günther Oettinger (Commissioner)
Other Lobbyists -
Date 19 Nov 2015 Location Brussels Subject TTIP Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Miguel Ceballos Baron (Cabinet member)
- Maria Asenius (Cabinet member)
Other Lobbyists